Literature DB >> 26203606

Queens beat one-eyed jacks, but nobody's played the ace yet. Adipokines as chronic obstructive pulmonary disease biomarkers.

Jeffrey L Curtis1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26203606      PMCID： PMC4566404          DOI： 10.1513/AnnalsATS.201505-256ED

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  16 in total

1.  Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression.

Authors:  Yeon-Mok Oh; Byeong-Ho Jeong; Sook-Young Woo; Su-Young Kim; Hojoong Kim; Ji-Hyun Lee; Seong Yong Lim; Chin Kook Rhee; Kwang Ha Yoo; Jin Hwa Lee; Hyoung Kyu Yoon; Don D Sin; Sang-Do Lee; Eun Kyung Kim; Hye Yun Park
Journal:  Ann Am Thorac Soc       Date:  2015-07

Review 2.  Leptin, adiponectin and pulmonary diseases.

Authors:  Nour Ali Assad; Akshay Sood
Journal:  Biochimie       Date:  2012-03-14       Impact factor: 4.079

3.  Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease.

Authors:  K H Chan; S C Yeung; T J Yao; M S M Ip; A H K Cheung; M M W Chan-Yeung; J C W Mak
Journal:  Int J Tuberc Lung Dis       Date:  2010-09       Impact factor: 2.373

4.  Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin.

Authors:  Marie-Kathrin Breyer; Erica P A Rutten; Juanita H J Vernooy; Martijn A Spruit; Mieke A Dentener; Carla van der Kallen; Marleen M J vanGreevenbroek; Emiel F M Wouters
Journal:  Respir Med       Date:  2011-03-01       Impact factor: 3.415

Review 5.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

6.  Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.

Authors:  Masaru Suzuki; Hironi Makita; Jörgen Östling; Laura H Thomsen; Satoshi Konno; Katsura Nagai; Kaoruko Shimizu; Jesper H Pedersen; Haseem Ashraf; Piet L B Bruijnzeel; Rose A Maciewicz; Masaharu Nishimura
Journal:  Ann Am Thorac Soc       Date:  2014-12

7.  Adiponectin-deficient mice are protected against tobacco-induced inflammation and increased emphysema.

Authors:  Marina Miller; Alexa Pham; Jae Youn Cho; Peter Rosenthal; David H Broide
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-08       Impact factor: 5.464

8.  Antielastin autoimmunity in tobacco smoking-induced emphysema.

Authors:  Seung-Hyo Lee; Sangeeta Goswami; Ariel Grudo; Li-Zhen Song; Venkata Bandi; Sheila Goodnight-White; Linda Green; Joan Hacken-Bitar; Joseph Huh; Faisal Bakaeen; Harvey O Coxson; Sebastian Cogswell; Claudine Storness-Bliss; David B Corry; Farrah Kheradmand
Journal:  Nat Med       Date:  2007-04-22       Impact factor: 53.440

Review 9.  Application of 'omics technologies to biomarker discovery in inflammatory lung diseases.

Authors:  Craig E Wheelock; Victoria M Goss; David Balgoma; Ben Nicholas; Joost Brandsma; Paul J Skipp; Stuart Snowden; Dominic Burg; Arnaldo D'Amico; Ildiko Horvath; Amphun Chaiboonchoe; Hassan Ahmed; Stéphane Ballereau; Christos Rossios; Kian Fan Chung; Paolo Montuschi; Stephen J Fowler; Ian M Adcock; Anthony D Postle; Sven-Erik Dahlén; Anthony Rowe; Peter J Sterk; Charles Auffray; Ratko Djukanovic
Journal:  Eur Respir J       Date:  2013-02-08       Impact factor: 16.671

Review 10.  Efferocytosis and lung disease.

Authors:  Alexandra L McCubbrey; Jeffrey L Curtis
Journal:  Chest       Date:  2013-06       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.